In the presence of IMiDs, isatuximab also induces enhanced direct cell apoptosis, augmented PBMC-mediated ADCC in MM cell lines and patient samples, and CD38 expression on Tregs was decreased, thus affording a further relief from the immunosuppressive tumor niche [7]. The gene discussed is CD38; the disease is Miyoshi myopathy.